Kuros Biosciences AG appointed Daniel Geiger as Chief Financial Officer (CFO) as of May 1, 2023, who is transitioning from his current role as CFO-ad interim. Daniel Geiger quickly adapted to Kuros' culture and is a proven leader to develop and execute Kuros' pivotal growth strategy.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.74 CHF | +3.53% |
|
-0.84% | +236.39% |
Apr. 24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
Apr. 17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+236.39% | 468M | |
+16.74% | 121B | |
+18.11% | 110B | |
+17.23% | 25.98B | |
-24.10% | 19.27B | |
-18.56% | 15.99B | |
-17.89% | 15.66B | |
-47.75% | 14.5B | |
+57.48% | 14.47B | |
+5.54% | 13.91B |
- Stock Market
- Equities
- KURN Stock
- News Kuros Biosciences AG
- Kuros Biosciences AG Appoints Daniel Geiger as Chief Financial Officer